Harikrishnan S, Jeemon P, Mini G, et al. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. 2018.

Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 2020;76:2982-3021.

Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertension Res 2019;42:1235-1481.

Collaborators GRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 2018;392:1923-94.

Mohammad AM, Rashad HH, Habeeb QS, et al. Demographic, clinical and angiographic profile of coronary artery disease in kurdistan region of Iraq. Am J Cardiovasc Dis 2021;11:39.

Mohammad AM, Jehangeer HI, Shaikhow SK. Prevalence and risk factors of premature coronary artery disease in patients undergoing coronary angiography in Kurdistan, Iraq. BMC Cardiovasc Dis 2015;15:1-6.

Kurdistan Region Statistics Office. Kurdistan Map, http://www.krso.net/Default.aspx?page=category&c=kurdistan (2015).

Fuchs FD and Whelton PK. High blood pressure and cardiovascular disease. Hypertension 2020;75:285-92.

Liu J, Bu X, Wei L, et al. Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019. J Hypertension 2021;39:2488-96.

Oh HJ, Lee S, Lee E-K, et al. Association of blood pressure components with mortality and cardiovascular events in prehypertensive individuals: a nationwide population-based cohort study. Ann Medicine 2018;50:443-52.

Lida M, Ueda K, Okayama A, et al. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese--Nippon data 80. J Hum Hypert 2003;17:851-7.

Soenarta AA, Buranakitjaroen P, Chia YC, et al. An overview of hypertension and cardiac involvement in Asia: Focus on heart failure. J Clin Hypert 2020;22:423-30.

Wang A, Tian X, Zuo Y, et al. Control of Blood Pressure and Risk of Cardiovascular Disease and Mortality in Elderly Chinese: A Real-World Prospective Cohort Study. Hypertension 2022;79:1866-75.

Aljefree N, Ahmed F. Prevalence of cardiovascular disease and associated risk factors among adult population in the Gulf region: a systematic review. Adv Public Health 2015;2015:1-23.

Stein R, Ferrari F, Scolari F. Genetics, dyslipidemia, and cardiovascular disease: new insights. Curr Cardiol Rep 2019;21:1-12.

Chiuve SE, McCullough ML, Sacks FM, et al. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 2006;114:160-7.

Iestra J, Kromhout D, Van der Schouw Y, et al. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation 2005;112:924-34.

Leon AS, Bronas UG. Dyslipidemia and risk of coronary heart disease: role of lifestyle approaches for its management. Am J Lifestyle Med 2009;3:257-73.

World Health Organization. Global recommendations on physical activity for health. World Health Organization, 2010.

Li J, Siegrist J. Physical activity and risk of cardiovascular disease—a meta-analysis of prospective cohort studies. Int J Environ Res Public Health 2012;9:391-407.

Jeong S-W, Kim S-H, Kang S-H, et al. Mortality reduction with physical activity in patients with and without cardiovascular disease. Eur Heart J 2019;40:3547-55.

Arija V, Villalobos F, Pedret R, et al. Effectiveness of a physical activity program on cardiovascular disease risk in adult primary health-care users: the “Pas-a-Pas” community intervention trial. BMC Public Health 2017;17:1-11.

Lin H, Sardana M, Zhang Y, et al. Association of habitual physical activity with cardiovascular disease risk. Circ Res 2020;127:1253-60.

Edwards P, Tsouros AD. A healthy city is an active city: a physical activity planning guide. World Health Organization. Regional Office for Europe, 2008.

Khattab A, Javaid A, Iraqi G, et al. Smoking habits in the Middle East and North Africa: results of the BREATHE study. Respiratory Med 2012;106:S16-S24.

Siziya S, Muula AS, Rudatsikira E. Correlates of current cigarette smoking among in-school adolescents in the Kurdistan region of Iraq. Conflict Health 2007;1:1-7.

Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.

Baba S, Iso H, Mannami T, et al. Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the JPHC Study Cohort I. Eur J Preventive Cardiol 2006;13:207-13.

Patnode CD, Henderson JT, Coppola EL, et al. Interventions for tobacco cessation in adults, including pregnant persons: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021;325:280-98.

Farmanfarma KK, Ansari-Moghaddam A, Zareban I, et al. Prevalence of type 2 diabetes in Middle–East: Systematic review& meta-analysis. Primary Care Diabetes 2020;14:297-304.

De Rosa S, Arcidiacono B, Chiefari E, et al. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol 2018;9:2.

Kim HK, Lee JB, Kim SH, et al. Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans. J Diabetes 2016;8:657-66.